The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 190.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 10.00 (5.405%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 190.00
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

2 Oct 2019 16:12

RNS Number : 5695O
Synectics PLC
02 October 2019
 

Synectics plc

("Synectics" or the "Company")

 

Director/PDMR dealings

 

2 October 2019

 

HMRC Approved Employee Share Acquisition Plan ("ESAP")

 

Synectics (AIM: SNX), a leader in the design, integration, control and management of advanced surveillance technology and networked security systems, has been notified that the Trustee of the ESAP purchased on 1 October 2019 9,279 ordinary shares of 20 pence each in the Company ("Shares") at £1.53 per Share in accordance with the ESAP's rules and on behalf of all ESAP participants, in respect of the six-month accumulation period ended on 30 September 2019.

 

Under the terms of the ESAP, participating members, including employees and certain Directors of the Company, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of Shares at the end of the six-month accumulation period (the "Period") based upon the contributions made in the Period and determined by the lowest share price at either the beginning of the Period or on the date of purchase. In this instance the share price used for the allocation of the number of Shares for ESAP purposes was the price per Share on the date of purchase.

 

The Trustee also reinvested the Company's interim dividend paid to shareholders on 20 September 2019 and purchased on 1 October 2019 511 Shares at £1.53 per Share in accordance with the ESAP's rules.

 

As a result of these purchases, the Company has been notified that Paul Webb, Chief Executive Director, has acquired an interest in 652 Shares and that Greg Alcorn, a PDMR of the Company, has acquired an interest in 604 Shares.

 

Performance Share Plan ("PSP")

 

The Company has also been notified that on 1 October 2019, David Gavin, a PDMR of the Company, exercised options over Shares which had previously vested under the performance criteria of the PSP and sold the Shares at a price of £X per Share, as follows:

 

Name

Position

Status

PSP options exercised

Shares retained in own name

Shares sold

David Gavin

General Manager, Synectic Systems Group

PDMR

10,000

-

10,000

 

Full details of the PSP are set out in the Company's Annual Report for the year ended 30 November 2018.

 

Interests in Shares

 

Following these transactions, the interests of Paul Webb, Greg Alcorn and David Gavin in Shares are as follows:

 

Name

Shares Held

Interest in Shares in Share Schemes

Resultant Total Interest

% of Issued Share Capital

Paul Webb

52,115

248,149

300,264

1.69

Greg Alcorn

0

12,477

12,477

0.07

David Gavin

0

2,000

2,000

0.01

 

 

For further information, please contact:

 

Synectics plc

Claire Stewart, Company Secretary

Tel: +44(0) 1527 850 080

 

Shore CapitalTom Griffiths / Henry WillcocksTel: +44 (0) 20 7408 4050

 

The information below (set out in accordance with the requirements of EU Market Abuse Regulation) provides further detail:

  1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Names 

Paul Webb

2

 

Reason for the notification

a)

 

Position/status

 

Director

b)

 

Initial notification /Amendment 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name 

Synectics plc

b)

 

LEI

213800C1F7YZH96U2Z49

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Ordinary Shares of 20p each

b)

Identification code 

 

GB0007156838

c)

 

Nature of the transaction 

 

Purchase (by employee share acquisition plan)

d)

 

Price(s) and volume(s)

Price(s)

Volume(s)

153p

652 shares

d)

 

Aggregated information 

- Aggregated volume

- Price

 

n/a

 

e)

 

Date of the transaction 

01 October 2019

f)

 

Place of the transaction

London Stock Exchange (XLON)

 

  1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Names 

Greg Alcorn

2

 

Reason for the notification

a)

 

Position/status

 

PDMR

b)

 

Initial notification /Amendment 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name 

Synectics plc

b)

 

LEI

213800C1F7YZH96U2Z49

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Ordinary Shares of 20p each

b)

Identification code 

 

GB0007156838

c)

 

Nature of the transaction 

 

Purchase (by employee share acquisition plan)

d)

 

Price(s) and volume(s)

Price(s)

Volume(s)

153p

604 shares

d)

 

Aggregated information 

- Aggregated volume

- Price

 

n/a

e)

 

Date of the transaction 

01 October 2019

f)

 

Place of the transaction

London Stock Exchange (XLON)

 

 

  1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Names 

David Gavin

2

 

Reason for the notification

a)

 

Position/status

 

PDMR

b)

 

Initial notification /Amendment 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name 

Synectics plc

b)

 

LEI

213800C1F7YZH96U2Z49

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Ordinary Shares of 20p each

b)

Identification code 

 

GB0007156838

c)

 

Nature of the transaction 

 

Exercise of options and subsequent on-market sale of shares

d)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil (exercise price)

153p (sale price)

10,000 shares

d)

 

Aggregated information 

- Aggregated volume

- Price

 

n/a

e)

 

Date of the transaction 

01 October 2019

f)

 

Place of the transaction

London Stock Exchange (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEASEAEEPNFFF
Date   Source Headline
4th Feb 20097:00 amRNSInterim Results
16th Jan 200912:06 pmRNSNotification of Results
3rd Sep 20087:00 amRNSPreliminary Results
6th Feb 20087:01 amRNSInterim Results
16th Jan 20087:00 amRNSNotification of Results
6th Dec 20071:09 pmRNSCanc of AIM trading facility
6th Dec 20079:56 amRNSOffer Update
30th Nov 20077:01 amRNSOffer Update
29th Nov 20077:01 amRNSOffer Update
26th Nov 200712:34 pmRNSResult of EGM
23rd Nov 20079:57 amRNSRule 8.1- Synexus
19th Nov 20079:40 amRNSRule 8.1- Synexus
16th Nov 200710:00 amRNSRule 8.1- Synexus
15th Nov 20073:00 pmBUSRule 8.3 - Synexus Clinincal Research Plc
15th Nov 200712:07 pmBUSRule 8.3 - Synexus Clinical Research Plc
15th Nov 20079:16 amRNSRule 8.1- Synexus
14th Nov 20073:21 pmBUSRule 8.3 - Synexus Clinical Research Plc
13th Nov 20073:16 pmBUSRule 8.3 - Synexus Clinical Research Plc
7th Nov 20074:38 pmRNSOffer Document Posted
7th Nov 20077:02 amRNSOffer for Synexus
6th Nov 20079:10 amRNSRule 8.3- Synexus
22nd Oct 200710:46 amRNSHolding(s) in Company
19th Oct 20076:21 pmRNSResponse to price movement
28th Sep 20077:02 amRNSPre Close Statement
5th Sep 20078:33 amRNSBoard Change
5th Sep 20077:01 amRNSPreliminary Results
22nd Aug 20073:17 pmRNSHolding(s) in Company
22nd Aug 200711:19 amRNSAIM RULE 26
15th Jun 20071:26 pmRNSGrant of Options
13th Jun 20077:01 amRNSPreliminary Results
24th May 20074:24 pmRNSNotice of Results
8th Mar 20077:00 amRNSHolding(s) in Company
20th Feb 200712:33 pmRNSGrant of Options
7th Feb 20077:02 amRNSNorth American Contract Wins
7th Feb 20077:02 amRNSInterim Results
6th Feb 200710:14 amRNSDirector/PDMR Shareholding
5th Feb 20077:00 amRNSDirectorate Change
29th Jan 20072:58 pmRNSNotice of Results
26th Jan 20077:01 amRNSTrading Update
28th Dec 20064:36 pmRNSGrant of Options
22nd Dec 20069:37 amRNSTotal Voting Rights & Capital
5th Dec 20067:01 amRNSInterim Results
29th Nov 20063:25 pmRNSDirector/PDMR Shareholding
24th Nov 200611:53 amRNSNotice of Results
24th Oct 20067:01 amRNSAcquisition
4th Oct 20067:00 amRNSTrading Statement
18th Sep 20069:11 amRNSDirectorate Change
13th Jul 20067:01 amRNSIssue of Equity
20th Jun 200610:39 amRNSGrant of Options
14th Jun 20065:06 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.